The U.S. still hasn’t reached a high enough level of vaccination to achieve “herd immunity” because vaccine demand is falling. While only months ago, it was hard to get an appointment, now vaccines…
Several highly effective vaccines were developed at an unprecedented speed to combat the COVID-19 pandemic. During the phase 3 clinical trials, mRNA vaccines had vaccine efficacy of 94–95% in preventing symptomatic infections. After…